RBC Capital Raises Target Price for Abbott to $130

RBC Capital has recently adjusted its outlook on Abbott Laboratories (ABT, Financial), increasing its target price from $125 to$130. The firm continues to maintain an "Outperform" rating for the company, indicating a strong confidence in its potential for growth in the market. ...